Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

Andrx freed to market Dilacor XR bioequivalent

Jan. 3, 1997

Watson's first NDA product approved

Jan. 3, 1997

Two FDA approvals for Taro

Jan. 3, 1997

Lipid effects of two gestodene/ethinylestradiol combinations compared

Jan. 3, 1997

Ciprofloxacin ophthalmic solution effective in treating bacterial corneal ulcers

Jan. 3, 1997

Expanded use of acellular DTP vaccine approved

Dec. 31, 1996

Nutropin cleared for marketing

Dec. 31, 1996

Bayer antibacterial cleared for wider use by FDA

Dec. 31, 1996

FDA clears oral monotherapy for PID

Dec. 31, 1996

Bayer launches sustained-release calcium antagonist in U.K.

Dec. 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...